BeStock  
Stocks › Biotechnology › DFTX

Definium Therapeutics DFTX

US equityMarket cap rank #2233Biotechnology
$28.34 −$1.14 (-3.87%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.05 -1.02%
Open$29.14
Prev close$29.48
Day range$28.18 – $29.51
Volume3.24M
Market cap$3.88B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

DFTX at a glance

DFTX is priced at $28.34 right now, down 3.87% on the session. That puts its market value at $3.88B, 2233rd largest among the 3753 stocks we cover.

The 52-week range is $10.53 to $49.70. Today's price is about 45% of the way from the low to the high. Holders are ahead 165.4% over twelve months, but down 34.5% across the last three months.

On the chart it has slipped under both the 50-day ($35.18) and 200-day ($30.73) moving averages; RSI is 34, and the last 30 sessions moved at roughly 69% annualized volatility.

In the quarter ended Sep 2026 the company brought in $0.00 of revenue, and a net loss of $50.96M.

14 analysts follow the stock and the average call is "buy". The mean target, $74.31, sits 162.2% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$28.05 / $28.65
Average price today$28.86
Volume3.24MAvg (90d) 2.02M
Turnover$93.44M
Turnover rate2.53%of shares outstanding
Volume ratio1.83vs. recent average pace
Day amplitude4.51%
Market cap$3.88B
Float market cap$3.63B
Shares outstanding128.19M
EPS (TTM)-$2.06
P/B4.01
Book value / share$7.07
Net profit (TTM)-$282.01M
Net assets$968.02M
30-day volatility69.1%annualized
Avg daily range (ATR)7.05%of price, 14 days
Max drawdown (1y)-41.5%-41.5% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

14 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 47.8 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability3.3
Momentum56.2
Financial health61.8
Analyst view95.2

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$74.31+162.2% vs. current price
Consensus ratingBuy14 analysts covering
Morningstar fair value$37.00Price is below fair value

Wall Street’s average 12-month target is $74.31, 162.2% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $37.00, so shares trade 23.4% below that estimate. On earnings multiple, it sits in the 9th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-3.9%
1 week
-11.7%
1 month
-21.3%
3 months
-34.5%
6 months
+26.0%
Year to date
+111.7%
1 year
+165.4%
Day range
$28.18$29.51
52-week range
$10.53$49.70

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-14.6%Bearish
Price vs 50-day average-19.4%Bearish
Price vs 200-day average-7.8%Bearish
50-day vs 200-day50d above 200dBullish
RSI (14)33.7Bearish
MACD (12,26,9)-1.77Bearish
Bollinger band position10%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How DFTX ranks on BeStock

Market value#2224 of 3734
Closeness to 52-week high#2781 of 3724
Dollar volume today#1025 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

DFTX is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on DFTX.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on DFTX

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

DFTX stock: common questions

Where is DFTX trading right now?

$28.34 is the latest print for DFTX, a move of -3.87% against yesterday's close of $29.48. Today's low and high so far: $28.18 and $29.51.

How big is Definium Therapeutics?

Equity value comes to $3.88B at the current price. By that measure it is number 2233 of the 3753 names in our coverage.

What's the 52-week trading range for Definium Therapeutics?

The year's floor is $10.53 and the ceiling $49.70. Shares are 43.0% away from that ceiling.

What's the dividend situation for DFTX?

Our data shows no dividend paid by Definium Therapeutics over the trailing twelve months.

What are analysts saying about DFTX?

Of 14 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $74.31, with the most cautious at $55.00 and the most optimistic at $91.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on DFTX.

Sign in to join the discussion.

Scroll to Top